Correlation Between Kodiak Sciences and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kodiak Sciences and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kodiak Sciences and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kodiak Sciences and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Kodiak Sciences and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kodiak Sciences with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kodiak Sciences and Pieris Pharmaceuticals.
Diversification Opportunities for Kodiak Sciences and Pieris Pharmaceuticals
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kodiak and Pieris is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Kodiak Sciences and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Kodiak Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kodiak Sciences are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Kodiak Sciences i.e., Kodiak Sciences and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kodiak Sciences and Pieris Pharmaceuticals
Considering the 90-day investment horizon Kodiak Sciences is expected to generate 0.55 times more return on investment than Pieris Pharmaceuticals. However, Kodiak Sciences is 1.83 times less risky than Pieris Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 324.00 in Kodiak Sciences on September 1, 2024 and sell it today you would earn a total of 343.00 from holding Kodiak Sciences or generate 105.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kodiak Sciences vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Kodiak Sciences |
| Pieris Pharmaceuticals |
Kodiak Sciences and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kodiak Sciences and Pieris Pharmaceuticals
The main advantage of trading using opposite Kodiak Sciences and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kodiak Sciences position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Kodiak Sciences vs. Reviva Pharmaceuticals Holdings | Kodiak Sciences vs. Eyenovia | Kodiak Sciences vs. Cognition Therapeutics | Kodiak Sciences vs. Transcode Therapeutics |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |